WARPTECHNEWS · LAB
HomeAIBusinessTechArchive
WARPTECH LAB NEWS

Warptech Lab News aggrega le notizie più rilevanti da oltre 700 fonti internazionali, con classificazione AI, TL;DR sintetici e timeline cluster su singole storie.

Navigazione

  • Home
  • Archivio
  • Editor's Brief
  • Cerca
  • Il tuo account
  • Newsletter tech/AI

Informazioni legali

  • Privacy Policy
  • Termini di servizio
  • Cookie Policy

© 2026 Sparktech S.R.L. — Tutti i diritti riservati. Sito gestito e manutenuto da Sparktech S.R.L.

Sede legale: Corso Libertà 55, 13100 Vercelli (VC), Italia · P.IVA / C.F. 02835910023 · Contatti: admin@warptechlab.com

Home
Storia in 9 fonti

FDA approves 1st-of-its-kind pill to reduce cholesterol

The Food and Drug Administration (FDA) approved on Thursday a first-of-its-kind oral option that can lower "bad" LDL cholesterol with a daily pill instead of a shot.

Raccontata dabiopharmadive.comcnn.comnbcnews.comthestar.combenzinga.comeconomictimes.indiatimes.comfortune.comupi.comabcnews.com

Confronto fonti

6 prospettive sulla stessa storia
AI · summaries
abcnews.comStai leggendo6 h fa

FDA approves 1st-of-its-kind pill to reduce cholesterol

The Food and Drug Administration (FDA) approved on Thursday a first-of-its-kind oral option that can lower "bad" LDL cholesterol with a daily pill instead of a shot.

originale

Timeline cronologica

  1. giovedì 16 luglio 2026·biopharmadive.com

    Merck wins first approval of a PCSK9 cholesterol pill

    The speedy clearance of Lipfendra is an important milestone for Merck and the result of a controversial voucher program put in place by former commissioner Marty Makary.

  2. giovedì 16 luglio 2026·cnn.com

    Merck’s cholesterol pill gets US FDA approval | CNN

    Merck said on Thursday the U.S. FDA has approved its cholesterol pill, the first of its kind to receive the health regulator’s ​nod, bolstering the drugmaker’s efforts to…

thestar.com
10 h fa

FDA approves a first-of-its-kind pill to cut cholesterol in high-risk patients

WASHINGTON (AP) — The Food and Drug Administration has approved a first-of-its-kind pill that can drastically reduce cholesterol in a way that's previously only been available with expensive, injectable drugs.

Leggi questa versione → originale
upi.com7 h fa

FDA approves first pill to significantly lower 'bad' cholesterol - UPI.com

The Food and Drug Administration on Thursday approved Merck's Lipfendra, which some have hailed as a breakthrough in cholesterol management.

Leggi questa versione → originale
fortune.com8 h fa

The cholesterol shot you couldn’t afford is now a pill | Fortune

The FDA has cleared Merck’s Lipfendra for patients whose artery‑clogging cholesterol remains high despite statins.

Leggi questa versione → originale
economictimes.indiatimes.com9 h fa

Merck gets US FDA nod for first-in-its-class oral cholesterol drug

The U.S. FDA has approved Merck's new cholesterol-lowering pill, Lipfendra. This oral medication works by blocking the PCSK9 protein, which helps lower bad cholesterol. Lipfendra offers an alternative for patients who…

Leggi questa versione → originale
nbcnews.com15 h fa

FDA approves new kind of cholesterol pill

Merck’s pill, called Lipfendra, is a PCSK9 inhibitor, which works in a different way than a statin to lower cholesterol.

Leggi questa versione → originale
  • giovedì 16 luglio 2026·nbcnews.com

    FDA approves new kind of cholesterol pill

    Merck’s pill, called Lipfendra, is a PCSK9 inhibitor, which works in a different way than a statin to lower cholesterol.

  • giovedì 16 luglio 2026·thestar.com

    FDA approves a first-of-its-kind pill to cut cholesterol in high-risk patients

    WASHINGTON (AP) — The Food and Drug Administration has approved a first-of-its-kind pill that can drastically reduce cholesterol in a way that's previously only been available…

  • giovedì 16 luglio 2026·benzinga.com

    FDA Approval Adds New Cholesterol Treatment Option in Merck Portfolio - Merck & Co (NYSE:MRK)

    Merck's Lipfendra wins FDA approval as the first oral PCSK9 inhibitor for adults with high LDL cholesterol after positive Phase 3 results.

  • giovedì 16 luglio 2026·economictimes.indiatimes.com

    Merck gets US FDA nod for first-in-its-class oral cholesterol drug

    The U.S. FDA has approved Merck's new cholesterol-lowering pill, Lipfendra. This oral medication works by blocking the PCSK9 protein, which helps lower bad cholesterol. Lipfendra…

  • giovedì 16 luglio 2026·fortune.com

    The cholesterol shot you couldn’t afford is now a pill | Fortune

    The FDA has cleared Merck’s Lipfendra for patients whose artery‑clogging cholesterol remains high despite statins.

  • giovedì 16 luglio 2026·upi.com

    FDA approves first pill to significantly lower 'bad' cholesterol - UPI.com

    The Food and Drug Administration on Thursday approved Merck's Lipfendra, which some have hailed as a breakthrough in cholesterol management.

  • venerdì 17 luglio 2026·abcnews.com

    FDA approves 1st-of-its-kind pill to reduce cholesterol

    The Food and Drug Administration (FDA) approved on Thursday a first-of-its-kind oral option that can lower "bad" LDL cholesterol with a daily pill instead of a shot.